Cargando…

Clinical Predictors of Pseudomonas aeruginosa Bacteremia in Emergency Department

OBJECTIVES: Pseudomonas aeruginosa shows higher mortality rate compared to other bacterial infections and is susceptible to a limited number of antimicrobial agents. Considering inadequate empirical treatment of Pseudomonas bacteremia has been associated with increased mortality, it is important for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Yongsoon, Paik, Jin Hui, Kim, Ji Hye, Han, Seung Baik, Durey, Areum
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174785/ https://www.ncbi.nlm.nih.gov/pubmed/30345116 http://dx.doi.org/10.1155/2018/7581036

Ejemplares similares

Prognostic Factors Predicting Poor Outcome in Cancer Patients with Febrile Neutropenia in the Emergency Department: Usefulness of qSOFA
por: Lee, Seung Jae, et al.
Publicado: (2018)

Tracheal Rupture Related to Endotracheal Intubation during Cardiopulmonary Resuscitation
por: Jung, Hyun Min, et al.
Publicado: (2019)

Lymphopenia as a predictor of bacteremia in the emergency department
por: Lowsby, R, et al.
Publicado: (2014)

Symptomatic bradycardia due to nicotine intoxication
por: Paik, Jin Hui, et al.
Publicado: (2018)

Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae
por: Bang, Ji Hwan, et al.
Publicado: (2013)

Pseudomonas aeruginosa bacteremia among liver transplant recipients
por: Liu, Taohua, et al.
Publicado: (2018)

Ceftolozane/Tazobactam Dosing Requirements Against Pseudomonas aeruginosa Bacteremia
por: Ruiz, Jesus, et al.
Publicado: (2020)

Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
por: Babich, Tanya, et al.
Publicado: (2022)

Predictors of Appropriate Antibiotic Use in Bacteremia Patients Presenting at the Emergency Department
por: Phungoen, Pariwat, et al.
Publicado: (2019)

P205: An outbreak of polyclonal pseudomonas aeruginosa bacteremia in hemodialysis patients
por: Ciobotaro, P, et al.
Publicado: (2013)

Machine learning model for predicting ciprofloxacin resistance and presence of ESBL in patients with UTI in the ED
por: Lee, Hyun-Gyu, et al.
Publicado: (2023)

Predictors of bacteremia in febrile infants under 3 months old in the pediatric emergency department
por: Guo, Bei-Cyuan, et al.
Publicado: (2023)

Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality
por: Zhang, Yulin, et al.
Publicado: (2020)

Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study
por: Kim, Hyo Sup, et al.
Publicado: (2017)

Trends in Pseudomonas aeruginosa (P. aeruginosa) Bacteremia during the COVID-19 Pandemic: A Systematic Review
por: Ng, Qin Xiang, et al.
Publicado: (2023)

A Case of Scrub Typhus complicated with a Splenic Infarction
por: Durey, Areum, et al.
Publicado: (2018)

Prognostic role of time to positivity of blood culture in children with Pseudomonas aeruginosa bacteremia
por: Xu, Huiting, et al.
Publicado: (2020)

A rare case of Pseudomonas aeruginosa bacteremia in a newborn with 58 perforations in the small intestine
por: Xu, Yuanyuan, et al.
Publicado: (2021)

Clinical predictors of mortality in patients with pseudomonas aeruginosa infection
por: Frem, Jim Abi, et al.
Publicado: (2023)

Complete Genome Sequences of Two Pseudomonas aeruginosa Strains Isolated from Children with Bacteremia
por: Espinosa-Camacho, Luis F., et al.
Publicado: (2017)

Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
por: Li, Shuang, et al.
Publicado: (2018)

Pseudomonas aeruginosa bacteremia mortality and resistance trends in the Veterans’ Health Administration (VHA) system
por: Hojat, Leila, et al.
Publicado: (2022)

In host evolution of beta lactam resistance during active treatment for Pseudomonas aeruginosa bacteremia
por: Spottiswoode, Natasha, et al.
Publicado: (2023)

185. Pseudomonas aeruginosa (PA) Bacteremia and Patient Outcome during COVID-19 Pandemic
por: Vivekanandan, Renuga, et al.
Publicado: (2023)

Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy
por: Kim, Youn Jeong, et al.
Publicado: (2014)

Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies
por: Zhang, Yu, et al.
Publicado: (2016)

Pseudomonas aeruginosa bacteremia secondary to acute right leg cellulitis: case of community-acquired infection
por: Wahab, Asrul Abdul, et al.
Publicado: (2013)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

Molecular epidemiological survey of bacteremia by multidrug resistant Pseudomonas aeruginosa: the relevance of intrinsic resistance mechanisms
por: Dantas, Raquel Cristina Cavalcanti, et al.
Publicado: (2017)

Septic shock secondary to an acute necrotizing community-acquired pneumonia with bacteremia due to Pseudomonas aeruginosa
por: Riviere, P., et al.
Publicado: (2019)

Follow-up blood cultures in Pseudomonas aeruginosa bacteremia: A potential target for diagnostic stewardship
por: Green, Alexis L., et al.
Publicado: (2021)

2278. Emergence of Resistance and Associated Mortality during Persistent Pseudomonas aeruginosa Bacteremia in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients
por: Fontana, Lauren, et al.
Publicado: (2019)

Emerging therapies against infections with Pseudomonas aeruginosa
por: Tümmler, Burkhard
Publicado: (2019)

Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge
por: Tenover, Fred C., et al.
Publicado: (2022)

Pseudomonas aeruginosa Bacteremia in Children Over Ten Consecutive Years: Analysis of Clinical Characteristics, Risk Factors of Multi-drug Resistance and Clinical Outcomes
por: Yang, Mi Ae, et al.
Publicado: (2011)

Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
por: Bliziotis, Ioannis A., et al.
Publicado: (2011)

Persistent Bacteremia from Pseudomonas aeruginosa with In Vitro Resistance to the Novel Antibiotics Ceftolozane-Tazobactam and Ceftazidime-Avibactam
por: Gangcuangco, Louie Mar, et al.
Publicado: (2016)

Outbreak of Pseudomonas aeruginosa Bacteremia Infections among Stem-Cell Transplant Patients Related to Change in Prophylaxis
por: VerLee, Kerrie, et al.
Publicado: (2021)

Clinical scores and blood biomarkers for Prediction of bacteremia in emergency department patients: Bacteremia Assessment in Clinical Triage (BACT) study
por: Laukemann, S, et al.
Publicado: (2015)

Successful Treatment of Multi-Drug Resistant Pseudomonas aeruginosa Bacteremia with the Recommended Renally Adjusted Ceftolozane/Tazobactam Regimen
por: Patel, Ursula C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f02eu1ntn9b440hfhjlkr4928c